Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp

Journal of Pathology

Volumn 230, Issue 4, 2013, Pages 420-429

  Gonzalo, David Hernandez ^a   Lai, Keith K ^a   Shadrach, Bonnie ^a   Goldblum, John R ^a   Bennett, Ana E ^a   Downs Kelly, Erinn ^a   Liu, Xiuli ^a   Henricks, Walter ^a   Patil, Deepa T ^a   Carver, Paula ^a   Na, Jie ^a   Gopalan, Banu ^a   Rybicki, Lisa ^a   Pai, Rish K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

annexin A10; colon cancer; hyperplastic polyp; sessile serrated polyp adenoma

Indexed keywords

ANNEXIN; ANNEXIN A10; UNCLASSIFIED DRUG;

ARTICLE; COLON; COLON BIOPSY; COLON MUCOSA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PATHOLOGIST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECTUM ADENOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANNEXIN A10; COLON CANCER; HYPERPLASTIC POLYP; SESSILE SERRATED POLYP/ADENOMA;

ADENOMA; AGED; ANNEXINS; BIOPSY; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COLONIC NEOPLASMS; COLONIC POLYPS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84880130397     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4200     Document Type: Article

References (51)

1. Torlakovic E, Skovlund E, Snover DC, et al,. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27: 65-81.
2. Goldstein NS, Bhanot P, Odish E, et al,. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003; 119: 778-796.
3. Lash RH, Genta RM, Schuler CM,. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010; 63: 681-686.
4. O'Brien MJ, Yang S, Mack C, et al,. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006; 30: 1491-1501.
5. Spring KJ, Zhao ZZ, Karamatic R, et al,. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006; 131: 1400-1407.
6. Kambara T, Simms LA, Whitehall VLJ, et al,. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53: 1137-1144.
7. Kim YH, Kakar S, Cun L, et al,. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer 2008; 123: 2587-2593.
8. Vaughn CP, Wilson AR, Samowitz WS,. Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol 2009; 23: 151-156.
9. O'Brien MJ, Yang S, Clebanoff JL, et al., Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 2004; 28: 423-434.
10. Yang S, Farraye FA, Mack C, et al,. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 2004; 28: 1452-1459.
11. Hawkins NJ, Ward RL,. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001; 93: 1307-1313.
12. Mäkinen MJ,. Colorectal serrated adenocarcinoma. Histopathology 2007; 50: 131-150.
13. Weisenberger DJ, Siegmund KD, Campan M, et al,. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genet 2006; 38: 787-793.
14. Patil DT, Shadrach BL, Rybicki LA, et al,. Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status. Mod Pathol 2012; 25: 1423-1431.
15. Sweetser S, Smyrk TC, Sinicrope FA. Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol 2012; DOI: 10.1016/j.cgh.2012. 12.004.
16. Li D, Jin C, McCulloch C, et al,. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 2009; 104: 695-702.
17. Hiraoka S, Kato J, Fujiki S, et al,. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 2010; 139: 1503-1510, 1510.e1-3.
18. Vu HT, Lopez R, Bennett A, et al,. Individuals with sessile serrated polyps express an aggressive colorectal phenotype. Dis Colon Rectum 2011; 54: 1216-1223.
19. Lu F-I, Van Niekerk DW, Owen D, et al,. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol 2010; 34: 927-934.
20. Sawhney MS, Farrar WD, Gudiseva S, et al,. Microsatellite instability in interval colon cancers. Gastroenterology 2006; 131: 1700-1705.
21. Arain MA, Sawhney M, Sheikh S, et al., CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010; 105: 1189-1195.
22. Huang CS, Farraye FA, Yang S, et al,. The clinical significance of serrated polyps. Am J Gastroenterol 2011; 106: 229-240; quiz 241.
23. Snover DC,. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011; 42: 1-10.
24. Leggett B, Whitehall V,. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088-2100.
25. Fearon ER, Vogelstein B,. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
26. Rex DK, Ahnen DJ, Baron JA, et al,. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012; 107: 1315-1329; quiz 1314, 1330.
27. Lieberman DA, Rex DK, Winawer SJ, et al,. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143: 844-857.
28. Smyth GK,. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:Article 3.
29. Edgar R, Domrachev M, Lash AE,. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207-210.
30. Jones S, Zhang X, Parsons DW, et al,. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321: 1801-1806.
31. Rhodes DR, Yu J, Shanker K, et al., ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6: 1-6.
32. Farris AB, Misdraji J, Srivastava A, et al,. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008; 32: 30-35.
33. Feuerborn A, Küffer S, Gröne H-J,. Forkhead factors regulate epithelial plasticity: impact on cancer progression. Cell Cycle 2011; 10: 2454-2460.
34. Myatt SS, Lam EW-F,. The emerging roles of forkhead box (Fox) proteins in cancer. Nature Rev Cancer 2007; 7: 847-859.
35. Kaneda H, Arao T, Tanaka K, et al,. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res 2010; 70: 2053-2063.
36. Borgoño CA, Diamandis EP,. The emerging roles of human tissue kallikreins in cancer. Nature Rev Cancer 2004; 4: 876-890.
37. Henkhaus RS, Gerner EW, Ignatenko NA,. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells. Biol Chem 2008; 389: 757-764.
38. Bongers G, Muniz LR, Pacer ME, et al,. A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans. Gastroenterology 2012; 143: 730-740.
39. Moniz S, Veríssimo F, Matos P, et al,. Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2. Oncogene 2007; 26: 6071-6081.
40. Resnick MB, Konkin T, Routhier J, et al,. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 2005; 18: 511-518.
41. Dhawan P, Singh AB, Deane NG, et al., Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005; 115: 1765-1776.
42. Dhawan P, Ahmad R, Chaturvedi R, et al,. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. Oncogene 2011; 30: 3234-3247.
43. Türeci O, Koslowski M, Helftenbein G, et al., Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals. Gene 2011; 481: 83-92.
44. Matsuda M, Sentani K, Noguchi T, et al. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis. Pathol Int 2010; 60: 673-680.
45. Mussunoor S, Murray GI,. The role of annexins in tumour development and progression. J Pathol 2008; 216: 131-140.
46. Duncan R, Carpenter B, Main LC, et al,. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 2008; 98: 426-433.
47. Shimizu T, Kasamatsu A, Yamamoto A, et al,. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways. PLoS One 2012; 7: e45510.
48. Lu S-H, Chen Y-L, Shun C-T, et al,. Expression and prognostic significance of gastric-specific annexin A10 in diffuse- and intestinal-type gastric carcinoma. J Gastroenterol Hepatol 2011; 26: 90-97.
49. Van Baal JWPM, Milana F, Rygiel AM, et al,. A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma. Cell Oncol 2008; 30: 63-75.
50. Pai RK, Hart J, Noffsinger AE,. Sessile serrated adenomas strongly predispose to synchronous serrated polyps in non-syndromic patients. Histopathology 2010; 56: 581-588.
51. Caruso M, Moore J, Goodall GJ, et al,. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Arch 2009; 454: 291-302.